Nasdaq
華爾街日報Anixa Biosciences Shares Jump Over 15% In After-Hours Trading — Here's Why
Anixa Biosciences Inc. (NASDAQ:ANIX) shares surged 15.21% in after-hours trading on Thursday, reaching $5.53, after the company presented final Phase 1 clinical trial data for its investigational breast cancer vaccine.
Check out the current price of ANIX stock here.
Phase 1 Trial Results
The healthcare company presented final data Thursday at the 2025 San Antonio Breast Cancer Symposium. The trial, conducted with the Cleveland Clinic and funded by a U.S. Department of Defense grant, showed the vaccine met all major primary endpoints.
Protocol-defined immune responses occurred in 74% of participants.
Dr. G. Thomas Budd, principal investigator at the Cleveland Clinic, said, “The investigational α-lactalbumin vaccine was safe and well tolerated at the maximum tolerated dose and generated protocol-defined immune responses in 74% of participants—results that support continued clinical evaluation.”
See Also: Why Are cbdMD (YCBD) Shares Surging 55% After Hours?
The California-based company stated that final Phase 1 findings showed the vaccine was safe and well-tolerated at the maximum tolerated dose.
The trial enrolled 35 participants across three cohorts.
Next Steps
Anixa Biosciences noted that the trial data will inform a planned Phase 2 study design, including a potential combination trial with Keytruda in the neoadjuvant setting for newly diagnosed breast cancer patients.
Dr. Amit Kumar, Chairman and CEO of Anixa Biosciences, stated, “We look forward to engaging with regulators and advancing plans for a Phase 2 study.”
Trading Metrics
The stock of the clinical-stage biotech has gained 106.90% year to date.
Anixa Biosciences has a market capitalization of $158 million, with a 52-week range of $2.07 to $5.46.
Price Action: According to Benzinga Pro data, ANIX closed on Thursday at $4.80, down 6.43%.
Benzinga’s Edge Stock Rankings indicates ANIX stock has a positive price trend across all time frames. Track the performance of other players in this segment.
Read Next:
Photo courtesy: Shutterstock
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.